130 related articles for article (PubMed ID: 22524741)
1. Invasive papillary carcinoma of the breast: an overview of twenty-four cases.
Vural O; Alnak A; Altundag K
Am Surg; 2012 Mar; 78(3):E144-5. PubMed ID: 22524741
[No Abstract] [Full Text] [Related]
2. Invasive micropapillary carcinoma of breast: an under-recognized entity. a series of eight cases.
Uddin Z; Idrees R; Aftab K; Kayani N
Breast J; 2012; 18(3):267-71. PubMed ID: 22583197
[TBL] [Abstract][Full Text] [Related]
3. The sensitivity and specificity of estrogen receptor, progesterone receptor and HER-2 staining in core biopsies of invasive breast carcinomas.
Frederik P; Cecile C; Tjalma WA
Breast J; 2007; 13(4):436-7. PubMed ID: 17593058
[No Abstract] [Full Text] [Related]
4. Immunohistochemical expression of epidermal growth factor receptor in breast cancer.
Nozoe T; Mori E; Iguchi T; Egashira A; Adachi E; Matsukuma A; Ezaki T
Breast Cancer; 2011 Jan; 18(1):37-41. PubMed ID: 20204554
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].
Wang YJ; Wang N; Wang B; Qin WX; Xue CY
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082
[TBL] [Abstract][Full Text] [Related]
6. Optimal surveillance for postoperative metastasis in breast cancer patients.
Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer and brain metastases.
Sait B; Cinar E; Altundag K
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):84. PubMed ID: 19751969
[No Abstract] [Full Text] [Related]
8. [Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].
Zhang P; Xu BH; Ma F; Li Q
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):128-31. PubMed ID: 20403244
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with bone metastasis in breast cancer: a preliminary study in an Indonesian population.
Irawan C; Hukom R; Prayogo N
Acta Med Indones; 2008 Oct; 40(4):178-80. PubMed ID: 19153424
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancers: unique clinical presentations and outcomes.
Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
[TBL] [Abstract][Full Text] [Related]
11. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior.
Pettinato G; Manivel CJ; Panico L; Sparano L; Petrella G
Am J Clin Pathol; 2004 Jun; 121(6):857-66. PubMed ID: 15198358
[TBL] [Abstract][Full Text] [Related]
12. Triple-negative breast cancer.
Oncology (Williston Park); 2010 Oct; 24(10 Suppl):40a. PubMed ID: 21275325
[No Abstract] [Full Text] [Related]
13. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
14. Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved.
Saita C; Goto R; Aruga T; Idera N; Honda Y; Horiguchi K; Miyamoto H; Horiguchi S; Yamashita T; Kuroi K
BMC Res Notes; 2016 Jan; 9():46. PubMed ID: 26813772
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer: a multicentric study.
Culell P; Solernou L; Tarazona J; Roma J; Martí E; Miguel A; Buxó J; Yanguas C; Badal JM
Breast J; 2007; 13(2):213-5. PubMed ID: 17319872
[No Abstract] [Full Text] [Related]
16. Medullary carcinoma of the breast: a brief report from a tertiary care center.
Petekkaya I; Babacan T; Sarici F; Gezgen G; Roach EC; Kizilarslanoglu MC; Altundag K
J BUON; 2013; 18(3):798. PubMed ID: 24065502
[No Abstract] [Full Text] [Related]
17. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
[TBL] [Abstract][Full Text] [Related]
18. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological characteristics of breast cancer.
Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
[TBL] [Abstract][Full Text] [Related]
20. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
